Carnegie Institution

NEW YORK (GenomeWeb) – A US District Court late last month threw out a lawsuit filed by a former University of Massachusetts researcher against the Carnegie Institution of Washington over inventorship of seminal intellectual property related to the discovery of RNA interference.

Australian expressed RNAi firm Benitec Biopharma provided an update on its research and development activities late last month, reporting that it remains on track to move its lead drug candidate, the hepatitis C therapy TT-034, into the clinic as early as this month.

Odyssey Thera, University of Pennsylvania, and Carnegie Institute of Washington Awarded US Patents